Proactiveinvestors United Kingdom RNS press releases https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom RNS press releases RSS feed en Sun, 26 May 2019 22:34:58 +0100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[RNS press release - IMMUNE SUPPRESSOR CELLS PROMOTE METASTASIS ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190426070008_14052748 Fri, 26 Apr 2019 07:00:08 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190426070008_14052748 <![CDATA[RNS press release - Parsortix used in new cancer assessment technique ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190418070008_14045574 Thu, 18 Apr 2019 07:00:08 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190418070008_14045574 <![CDATA[RNS press release - LUNG CANCER STUDY USES ANGLE'S PARSORTIX SYSTEM ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190412070006_14038627 Fri, 12 Apr 2019 07:00:06 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190412070006_14038627 <![CDATA[RNS press release - AACR 2019 ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190404070005_14028176 Thu, 04 Apr 2019 07:00:05 +0100 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190404070005_14028176 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190311070011_13996486 Mon, 11 Mar 2019 07:00:11 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190311070011_13996486 <![CDATA[RNS press release - ENROLMENT COMPLETE FOR FDA CLINICAL STUDY ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190307070013_13993141 Thu, 07 Mar 2019 07:00:13 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190307070013_13993141 <![CDATA[RNS press release - FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190228070022_13984463 Thu, 28 Feb 2019 07:00:22 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190228070022_13984463 <![CDATA[RNS press release - CUSTOMER DEMONSTRATES NEW USE FOR PARSORTIX ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190225070006_13979565 Mon, 25 Feb 2019 07:00:06 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190225070006_13979565 <![CDATA[RNS press release - Research into role of immune cells in cancer ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190211070005_13964083 Mon, 11 Feb 2019 07:00:05 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190211070005_13964083 <![CDATA[RNS press release - Interim Results ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190131070009_13952734 Thu, 31 Jan 2019 07:00:09 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190131070009_13952734 <![CDATA[RNS press release - NEW APPLICATION FOR PARSORTIX IN CANCER ANALYSIS ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190129070009_13949575 Tue, 29 Jan 2019 07:00:09 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190129070009_13949575 <![CDATA[RNS press release - Second Price Monitoring Extn ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190111140558_13932369 Fri, 11 Jan 2019 14:05:58 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190111140558_13932369 <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190111140032_13932360 Fri, 11 Jan 2019 14:00:32 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190111140032_13932360 <![CDATA[RNS press release - Second Price Monitoring Extn ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190111110538_13932118 Fri, 11 Jan 2019 11:05:38 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190111110538_13932118 <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190111110035_13932108 Fri, 11 Jan 2019 11:00:35 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190111110035_13932108 <![CDATA[RNS press release - Second Price Monitoring Extn ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190111090527_13931827 Fri, 11 Jan 2019 09:05:27 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190111090527_13931827 <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190111090028_13931824 Fri, 11 Jan 2019 09:00:28 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190111090028_13931824 <![CDATA[RNS press release - Second Price Monitoring Extn ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190110164113_13931006 Thu, 10 Jan 2019 16:41:13 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190110164113_13931006 <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190110163602_13930995 Thu, 10 Jan 2019 16:36:02 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190110163602_13930995 <![CDATA[RNS press release - BREAKTHROUGH CANCER RESEARCH USING PARSORTIX ]]> https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190110160102_13930951 Thu, 10 Jan 2019 16:01:02 +0000 https://www.proactiveinvestors.co.uk/LON:AGL/ANGLE-PLC/rns/LSE20190110160102_13930951